[Effects of ginkgolide B on proliferation,  phagocytosis,  NO and ROS production of murine peritoneal macrophages in vitro].
OBJECTIVE
To explore the potential immunomodulatory effects and related mechanisms of ginkgolide B (GB),  a known potent antagonist of platelet-activating factor receptor,  we investigated the proliferation,  phagocytosis,  NO and ROS production of macrophage.


METHODS
After murine peritoneal macrophages (PMs) preparation,  PMs were treated with different concentrations of GB before culture time and then activated by LPS. Drug toxicology and PM proliferation were measured by MTT assays. Fluorescent beads ingestion and flow cytometry were used to assess phagocytosis of LPS-activated PMs. Griess reagent system was used to determine the amount of LPS-induced NO production. H2DCFDA labeling and flow cytometry were used to trace ROS level of both rest and LPS-activated PMs.


RESULTS
In a dose-dependent manner,  GB (5,  10,  and 20 μmol/L) significantly suppressed the phagocytosis as well as NO and ROS production at 24 h and inhibited cell proliferation at 48 h after LPS stimulation.


CONCLUSIONS
According to these interesting effects of GB on macrophage behaving and functioning,  it's quite reasonable to do further studies of GB as a nature occurring immunomodulator candidate.
Institute of Tissue Transplantation and Immunology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. wangxiaodongbinghuo@126.com
Xiao-dong
XD
Wang
Yao-ying
YY
Zeng
Bing
B
Song
D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D046934:Ginkgolides / Q000494:pharmacology*; D007155:Immunologic Factors / Q000494:pharmacology*; D007783:Lactones / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000276:immunology; D008262:Macrophage Activation / Q000187:drug effects; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009569:Nitric Oxide / Q000096:biosynthesis*; D010587:Phagocytosis / Q000187:drug effects*; D017382:Reactive Oxygen Species / Q000378:metabolism*
D046934:Ginkgolides; D007155:Immunologic Factors; D007783:Lactones; D008070:Lipopolysaccharides; D017382:Reactive Oxygen Species; D009569:Nitric Oxide; C045856:ginkgolide B